Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
19/06/2025
Guggenheim: Reaffirming the rating for Dyne Therapeutics (DYN.US) from Buy to Buy, with a target price adjusted from $50.00 to $50.00.
Latest
3 m ago
The onshore Chinese yuan fell by 26 points against the US dollar from Tuesday night's closing.
5 m ago
The US Dollar Index saw a U-shaped reversal on the day the Federal Reserve's statement was released, with a slight increase of over 0.1%.
7 m ago
Goldman Sachs: Powell does not sound particularly dovish.
7 m ago
Goldman Sachs: Powell doesn't sound particularly dovish.
7 m ago
The US dollar index rose on the 18th.
See all latest